Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays (Q34202805)

31 July 2017

Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays (English)

1 reference

31 July 2017

0 references

Angela M Caliendo

1

1 reference

31 July 2017

Kirsten St George

2

1 reference

31 July 2017

Jessica Allega

3

1 reference

31 July 2017

Arlene C Bullotta

4

1 reference

31 July 2017

Lisa Gilbane

5

1 reference

31 July 2017

Charles R Rinaldo

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of Clinical Microbiology

31 July 2017

1 reference

31 July 2017

40

1 reference

31 July 2017

5

1 reference

31 July 2017

1581-1586

1 reference

Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Infection in organ-transplant recipients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Ganciclovir therapy for cytomegalovirus disease associated with renal transplants

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130923

Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients

28 October 2018

1 reference

12 December 2020

Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

12 December 2020

Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation

1 reference

12 December 2020

The economic impact of cytomegalovirus infection after liver transplantation

1 reference

12 December 2020

EVALUATION OF HUMAN CYTOMEGALOVIRUS GENE EXPRESSION IN THORACIC ORGAN TRANSPLANT RECIPIENTS USING NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION

1 reference

12 December 2020

Preemptive Therapy in Immunocompromised Hosts

1 reference

12 December 2020

Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients

1 reference

12 December 2020

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

1 reference

12 December 2020

Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients

1 reference

12 December 2020

Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection

1 reference

12 December 2020

Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group

1 reference

12 December 2020

Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay

1 reference

12 December 2020

Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients

1 reference

12 December 2020

Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis

1 reference

12 December 2020

Cytomegalovirus Disease as a Risk Factor for Graft Loss and Death After Orthotopic Liver Transplantation

1 reference

12 December 2020

An association between cytomegalovirus infection and chronic rejection after liver transplantation

1 reference

12 December 2020

10.1128/JCM.40.5.1581-1586.2002

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference